How to spot misleading GLP-1 patch marketing Red flags: any claim of containing "semaglutide" or "tirzepatide" (illegal without a prescription), before-and-after photos without clinical trial context, specific weight-loss promises ("lose 12+ lbs per month"), language like "Nature's Ozempic" or "works like Wegovy," and any implication of FDA review
Additionally, because Semaglutide can help reduce appetite, it is also prescribed for weight management in people with obesity or who are overweight and have health problems related to their weight
A more recent randomized, double-blind, placebo-controlled study in 30 patients with type 2 diabetes found that intravenous infusion of 600 mg of lipoic acid improved the response to the endothelium-dependent vasodilator acetylcholine but not to the endothelium-independent vasodilator, glycerol trinitrate (63)
Retatrutide is a novel triple-agonist peptide targeting GIP, GLP-1, and glucagon receptors simultaneously
Under physiological conditions, natural GLP-1 is secreted by the intestines in response to food intake, prompting insulin release and managing glucose levels
Anyone with Wilson's disease or any known copper-metabolism disorder should not use GHK-Cu at all this is the one hard contraindication, topical or injectable